908 Devices Inc. (MASS)
2.58
0.11 (4.45%)
At close: Jan 28, 2025, 3:51 PM
undefined% (undefined)
| Bid | 2.57 |
| Market Cap | 89.67M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.79 |
| PE Ratio (ttm) | -1.44 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 2.58 |
| Volume | 214,585 |
| Avg. Volume (20D) | 644,574 |
| Open | 2.48 |
| Previous Close | 2.47 |
| Day's Range | 2.42 - 2.62 |
| 52-Week Range | 1.81 - 7.91 |
| Beta | undefined |
About MASS
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials o...
Industry Medical - Devices
Sector Healthcare
IPO Date Dec 18, 2020
Employees 230
Stock Exchange NASDAQ
Ticker Symbol MASS
Website https://www.908devices.com
Analyst Forecast
According to 3 analyst ratings, the average rating for MASS stock is "Buy." The 12-month stock price forecast is $6, which is an increase of 133.01% from the latest price.
Buy 66.67%
Hold 33.33%
Sell 0.00%
Next Earnings Release
908 Devices Inc. is scheduled to release its earnings on Mar 4, 2025,
before market opens.
Analysts project revenue of $16.18M, reflecting a 12.74% YoY growth and earnings per share of -0.37, making a 60.87% increase YoY.
Analysts project revenue of $16.18M, reflecting a 12.74% YoY growth and earnings per share of -0.37, making a 60.87% increase YoY.
1 week ago
+46.97%
908 Devices shares are trading higher after the co...
Unlock content with
Pro Subscription
1 week ago
-1.49%
908 Devices shares are trading higher after the company reported preliminary Q4 revenues above estimates.
